{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:50Z","timestamp":1761986570670,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s41030-023-00219-x","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:09:00Z","timestamp":1680120540000},"page":"271-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Guillain\u2013Barr\u00e9 Syndrome due to COVID-19 Vero Cell Vaccination Associated with Concomitant COVID-19 Infection-induced ARDS and Treated Successfully by Therapeutic Plasma Exchange: A First Case Report from Vietnam"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-9544","authenticated-orcid":false,"given":"Sy","family":"Duong-Quy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc","family":"Huynh-Truong-Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien","family":"Nguyen-Quang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh","family":"Nguyen-Thi-Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Tran-Ngoc-Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam","family":"Nguyen-Van-Hoai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Do-Thi-Thu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinh","family":"Nguyen-Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tram","family":"Tang-Thi-Thao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh","family":"Nguyen-Tuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toi","family":"Nguyen-Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh","family":"Tran-Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Vu-Tran-Thien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"The","family":"Trinh-Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan","family":"Tran-Thai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thai","family":"Nguyen-Duy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huong","family":"Tran-Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh","family":"Vo-Thi-Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"219_CR1","unstructured":"https:\/\/www.who.int\/publications\/m\/item\/sinopharm-vero-cell---inactivated-covid-19-vaccine."},{"key":"219_CR2","unstructured":"https:\/\/www.fda.gov.ph\/covid-19-vaccine-vero-cell-inactivated-covid-19-vaccine-sinopharm\/ (accessed in 21 September 2023)"},{"key":"219_CR3","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2147\/IJGM.S310497","volume":"14","author":"NA El-Shitany","year":"2021","unstructured":"El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM, Eid B, Almukadi H, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389\u2013401. https:\/\/doi.org\/10.2147\/IJGM.S310497.","journal-title":"Int J Gen Med"},{"key":"219_CR4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1001\/jama.2021.5374","volume":"325","author":"J Chapin-Bardales","year":"2021","unstructured":"Chapin-Bardales J, Gee J, Myers T. Reactogenicity following receipt of mRNA-based COVID-19 vaccines. JAMA. 2021;325:2201\u20132. https:\/\/doi.org\/10.1001\/jama.2021.5374.","journal-title":"JAMA"},{"key":"219_CR5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijid.2021.04.047","volume":"106","author":"RAK Kadali","year":"2021","unstructured":"Kadali RAK, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: a randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021;106:376\u201381. https:\/\/doi.org\/10.1016\/j.ijid.2021.04.047.","journal-title":"Int J Infect Dis"},{"key":"219_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","volume":"21","author":"C Menni","year":"2021","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21:939\u201349. https:\/\/doi.org\/10.1016\/S1473-3099(21)00224-3.","journal-title":"Lancet Infect Dis"},{"key":"219_CR7","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/jcm10122629","volume":"10","author":"A Riad","year":"2021","unstructured":"Riad A, Sa\u011f\u0131ro\u011flu D, \u00dcst\u00fcn B, Pokorn\u00e1 A, Klugarov\u00e1 J, Attia S, et al. Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in turkey. J Clin Med. 2021;10:2629. https:\/\/doi.org\/10.3390\/jcm10122629.","journal-title":"J Clin Med"},{"key":"219_CR8","first-page":"39","volume":"4","author":"R Jayadevan","year":"2021","unstructured":"Jayadevan R, Shenoy R, Anithadevi TS. Survey of symptoms following COVID-19 vaccination in Indian. Medrxiv. 2021;4:39.","journal-title":"Medrxiv."},{"key":"219_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/vaccines9060556","volume":"9","author":"MM Hatmal","year":"2021","unstructured":"Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal MM, Al-Hatamleh MAI, Olaimat AN, Hatmal M, Alhaj-Qasem DM, Olaimat TM, et al. Side effects and perceptions following COVID-19 vaccination in Jordan: a randomized, cross-sectional study implementing machine learning for predicting severity of side effects. Vaccines. 2021;9:556. https:\/\/doi.org\/10.3390\/vaccines9060556.","journal-title":"Vaccines"},{"key":"219_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","volume":"111","author":"BQ Saeed","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021;111:219\u201326. https:\/\/doi.org\/10.1016\/j.ijid.2021.08.013.","journal-title":"Int J Infect Dis"},{"key":"219_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1080\/14760584.2022.2116008","volume":"21","author":"A Esmaeilzadeh","year":"2022","unstructured":"Esmaeilzadeh A, Maleki AJ, Moradi A, Siahmansouri A, Yavari MJ, Karami P, et al. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks. Expert Rev Vaccines. 2022;21:1377\u201394. https:\/\/doi.org\/10.1080\/14760584.2022.2116008.","journal-title":"Expert Rev Vaccines"},{"key":"219_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain\u2013Barr\u00e9 syndrome. Lancet. 2021;397:1214\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(21)00517-1.","journal-title":"Lancet"},{"key":"219_CR13","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.3201\/eid2712.211634","volume":"27","author":"SC Shao","year":"2021","unstructured":"Shao SC, Wang CH, Chang KC, Hung MJ, Chen HY, Liao SC. Guillain\u2013Barr\u00e9 syndrome associated with COVID-19 vaccination. Emerg Infect Dis. 2021;27:3175\u20138. https:\/\/doi.org\/10.3201\/eid2712.211634.","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"219_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.868667","volume":"25","author":"S Duong-Quy","year":"2022","unstructured":"Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Thi-Kim T, Nguyen-Quang T, Nguyen-Chi T, Tran-Xuan Q, Nguyen-Nhu V, Ngo C, Craig T. Guillain\u2013Barr\u00e9 syndrome in patient with SARS-CoV-2 PCR positivity treated successfully with therapeutic exchange plasma: a first case report from Vietnam. Front Neurol. 2022;25(13): 868667.","journal-title":"Front Neurol"},{"key":"219_CR15","doi-asserted-by":"publisher","first-page":"984658","DOI":"10.3389\/fpsyt.2022.984658","volume":"13","author":"S Duong-Quy","year":"2022","unstructured":"Duong-Quy S, Tran-Duc S, Hoang-Chau-Bao D, Bui-Diem K, Vu-Tran-Thien Q, Nguyen-Nhu V,  Tiredness, Depression, and sleep disorders in frontline healthcare workers during COVID-19 pandemic in Vietnam: a field hospital study. Front Psychiatry. 2022;13:984658. https:\/\/doi.org\/10.3389\/fpsyt.2022.984658.","journal-title":"Front Psychiatry"},{"key":"219_CR16","volume-title":"Guillain\u2013Barr\u00e9 syndrome and variants following COVID-19 vaccination: Report of 13 Cases","author":"K Jee-Eun","year":"2022","unstructured":"Jee-Eun K, Young GM, Je-Young S, et al. Guillain\u2013Barr\u00e9 syndrome and variants following COVID-19 vaccination: Report of 13 Cases. Sec Neuromuscular Disorders and Peripheral Neuropathies: Front Neurol; 2022."},{"key":"219_CR17","volume-title":"Case report: Post-COVID-19 vaccine recurrence of Guillain\u2013Barr\u00e9 syndrome following an antecedent parainfectious COVID-19-related GBS","author":"B Margherita","year":"2022","unstructured":"Margherita B, Francesco G, Stefano G, et al. Case report: Post-COVID-19 vaccine recurrence of Guillain\u2013Barr\u00e9 syndrome following an antecedent parainfectious COVID-19-related GBS. Sec Multiple Sclerosis and Neuroimmunology: Front Immunol; 2022."},{"key":"219_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","volume":"388","author":"HJ Willison","year":"2016","unstructured":"Willison HJ, Jacobs BC, van Doorn PA. Guillain\u2013Barr\u00e9 syndrome. Lancet. 2016;388:717\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(16)00339-1.","journal-title":"Lancet"},{"key":"219_CR19","unstructured":"Madhusudan S, Muralidharan J. Biomarkers in COVID-19: An up-to-date review. Front Pediatr (2021)."},{"key":"219_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/antiox10081221","volume":"10","author":"AM C\u00e9sar","year":"2011","unstructured":"C\u00e9sar AM, Cabrera C\u00e9sar E, Mart\u00edn-Monta\u00f1ez E, Sanchez Alvarez E, Lopez PM, Romero-Zerbo Y, E.C., et al. Acute lung injury biomarkers in the prediction of COVID-19 severity: total thiol, ferritin and lactate dehydrogenase. Antioxidants. 2011;10:1221. https:\/\/doi.org\/10.3390\/antiox10081221.","journal-title":"Antioxidants."},{"key":"219_CR21","first-page":"608130","volume":"12","author":"S Pei","year":"2021","unstructured":"Pei S, Jiachun F, Wei W, Hong-Liang Z. Intensive care and treatment of severe Guillain\u2013Barr\u00e9 syndrome. Front Pharmacol Sec Respir Pharmacol. 2021;12:608130.","journal-title":"Front Pharmacol Sec Respir Pharmacol."},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"2050313X2093347","DOI":"10.1177\/2050313X20933473","volume":"8","author":"K Philip","year":"2020","unstructured":"Philip K, Matthew D, Carol C, et al. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure. Sage Open Med Case Rep. 2020;8:2050313X20933473.","journal-title":"Sage Open Med Case Rep."},{"key":"219_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798.pub2","volume-title":"Plasma exchange for Guillain\u2013Barr\u00e9 syndrome","author":"JC Raphael","year":"2012","unstructured":"Raphael JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain\u2013Barr\u00e9 syndrome. Chichester, UK: Cochrane Database Syst Rev. John Wiley & Sons Ltd; 2012."},{"key":"219_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jca.21830","volume":"36","author":"V Altmayer","year":"2021","unstructured":"Altmayer V, Saheb S, Rohaut B, Marois C, Cao A, Gallo A, et al. Therapeutic plasma exchange in a critically ill COVID-19 patient. J Clin Apher. 2021;36:179\u201382. https:\/\/doi.org\/10.1002\/jca.21830.","journal-title":"J Clin Apher"},{"key":"219_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jfma.2020.04.023","volume":"119","author":"JH Lin","year":"2020","unstructured":"Lin JH, Chen YC, Lu CL, Hsu YN, Wang WJ. Application of plasma exchange in association with higher dose CVVH in cytokine storm complicating COVID-19. J Formos Med Assoc Taiwan Yi Zhi. 2020;119:1116\u20138. https:\/\/doi.org\/10.1016\/j.jfma.2020.04.023.","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"key":"219_CR26","doi-asserted-by":"publisher","first-page":"101587","DOI":"10.1016\/j.rmcr.2022.101587","volume":"36","author":"M Talalaev","year":"2022","unstructured":"Talalaev M, Pandav K, Mehendale M, Gonzalez L, Yatzkan MC, Yatzkan GD, et al. Treatment with therapeutic plasma exchange in severe COVID-19 pneumonia: a case report and review of the literature. Respir Med Case Rep. 2022;36:101587. https:\/\/doi.org\/10.1016\/j.rmcr.2022.101587.","journal-title":"Respir Med Case Rep."},{"key":"219_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-022-00188-7","author":"S Duong-Quy","year":"2022","unstructured":"Duong-Quy S, Huynh-Truong-Anh D, Nguyen-Thi-Kim T, Nguyen-Quang T, Nguyen-Chi T, Duong-Thi-Thanh V, Ngo C, Craig T. The use of therapeutic plasma exchange in the treatment of a pregnant woman with COVID-19-induced acute respiratory distress syndrome. Pulm Ther. 2022. https:\/\/doi.org\/10.1007\/s41030-022-00188-7.","journal-title":"Pulm Ther"},{"key":"219_CR28","doi-asserted-by":"publisher","first-page":"102920","DOI":"10.1016\/j.amsu.2021.102920","volume":"71","author":"I Zaid","year":"2021","unstructured":"Zaid I, Essaad O, Elai douni G, Aabdi M, Berrichi S, Taouihar S, et al. Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: cases series. Ann Med Surg. 2021;71:102920. https:\/\/doi.org\/10.1016\/j.amsu.2021.102920.","journal-title":"Ann Med Surg."}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-023-00219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-023-00219-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-023-00219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T10:20:19Z","timestamp":1690194019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-023-00219-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s41030-023-00219-x","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"type":"print","value":"2364-1754"},{"type":"electronic","value":"2364-1746"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}